Can Pharmacists Prescribe Abortion Pills to Improve Access?

January 21, 2025

A new initiative in Washington state is pioneering a path toward expanded access to abortion medications through an innovative pilot program spearheaded by Uplift International, a nonprofit organization. Known as the Pharmacist Abortion Access Project, this initiative enables trained pharmacists to prescribe abortion pills via telehealth. By implementing this model, proponents anticipate it could be adopted by other states, effectively increasing abortion accessibility nationwide. Abortion in Washington state is broadly legal up to the point of fetal viability, generally between 24 and 26 weeks of pregnancy. Despite its legality, many people still encounter significant barriers to accessing abortion services due to an array of factors, including geographical location and financial constraints. Dr. Beth Rivin, president and CEO of Uplift International, emphasizes the critical role of telehealth in overcoming these obstacles, noting that when pharmacists are empowered to prescribe medication abortions, it can significantly enhance access to these essential services.

The Pharmacist Abortion Access Project

In collaboration with Honeybee Health, an online pharmacy, Uplift International recruited and trained ten pharmacists to prescribe mifepristone and misoprostol. These medications, forming the standard U.S. Food and Drug Administration (FDA)-approved regimen for medical abortions, can be administered up to 10 weeks’ gestation. The training protocol was meticulously developed in partnership with Dr. Sarah Prager, a professor of obstetrics and gynecology at the University of Washington. By ensuring that patients can be referred to clinics for necessary in-person follow-up care, such as ultrasounds and blood tests, the program aims to offer comprehensive support throughout the abortion process.

A pivotal element of the platform is the communication it facilitates between pharmacists and patients. Patients can message pharmacists with questions, fostering a supportive dialogue throughout the process. Follow-up interactions occur at one week and around four to five weeks after the prescription is provided, ensuring a continued connection. Addressing safety concerns raised by anti-abortion groups, which argue that telemedicine for abortion pills poses health risks, recent research counters these claims. Findings, including a study indicating that 99.7% of patients did not experience serious complications, affirm that telehealth prescriptions are just as safe as in-person treatments. Moreover, 97.7% of patients did not require any additional follow-up care, further supporting the safety and efficacy of telehealth for medication abortions.

Addressing Safety Concerns and Opposition

The Heritage Foundation, a conservative group advocating for legislative changes under Project 2025, argues for banning telemedicine and mail-order abortion pills. They cite instances of abortion pills being administered without consent and push for stricter regulations on abortion medications. Despite these contentions, research robustly refutes the notion that telehealth prescriptions are unsafe, instead supporting the continuation and broader application of these services. The pilot program, which ran from October 31 to November 26, 2024, successfully prescribed medication abortions to 43 eligible individuals. To qualify, patients needed to be 18 years or older and provide a valid Washington address for mailing the medication. Importantly, proof of residency was not required, only a valid address. Washington’s shield laws protect medical providers from investigations by states where abortion is illegal if their residents obtain an abortion in Washington.

As the pilot program demonstrated considerable success, Uplift International now plans to expand the initiative within Washington state. The organization is exploring the possibility of allowing pharmacists to prescribe medication abortions in person from physical pharmacies. The ultimate goal is for other states to adopt this model, especially in the face of potential increased federal abortion restrictions under the new administration. Don Downing, a clinical pharmacy professor emeritus at the University of Washington and co-director of the project, points to Washington’s progressive pharmacy laws, recognizing pharmacists as healthcare providers since 1979, permitting them to prescribe various FDA-approved medications. He contrasts this with Idaho, a neighboring state with progressive pharmacy laws but starkly differing abortion policies, including a near-total ban, civil enforcement laws, and restrictions on minors traveling for abortions.

Expansion and Future Prospects

In Washington state, an initiative led by Uplift International is breaking new ground in expanding access to abortion medications through a pilot program. Named the Pharmacist Abortion Access Project, this program allows trained pharmacists to prescribe abortion pills via telehealth. Proponents predict that this model could be adopted by other states, effectively broadening abortion access nationwide. In Washington, abortion is generally legal up to fetal viability, which occurs between 24 and 26 weeks of pregnancy. Nonetheless, many individuals still face significant barriers to accessing abortion services due to geographic and financial challenges. Dr. Beth Rivin, president and CEO of Uplift International, underscores the essential role of telehealth in overcoming these obstacles. She notes that empowering pharmacists to prescribe medication abortions can greatly improve access to these crucial services, potentially setting a precedent for other regions to follow.

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later